Purpose: To review and discuss the available treatments for choroidal neovascularization (CNV) due to age-related macular degeneration (AMD) emphasizing to photodynamic therapy (PDT). Methods: Published papers from 1974 until 1999 related to AMD, its available treatments and PDT were reviewed. Results: The most used effective treatment for CNV is laser photocoa-gulation which does not have a major impact on the blindness due to AMD. Alternative techniques of prevention and treatment are under investigation including surgery, pharmacological antiangiogenic treatment and prevention with photocoagulation. PDT using verteporfin demonstrated effectiveness in closing CNV membranes in an experimental model. A clinical trial showed that a single co...
OBJECTIVE: To evaluate short-term safety and the effects on visual acuity and fluorescein angiograph...
OBJECTIVES: To evaluate safety and short-term visual acuity and fluorescein angiographic effects of ...
PURPOSE: To determine if photodynamic therapy with verteporfin (Visudyne; Novartis AG, Bulach, Switz...
BACKGROUND: Conventional photocoagulation of subfoveal choroidal neovascularization (CNV) is often a...
Abstract PURPOSE: To assess the effectiveness of photodynamic therapy (PDT) with verteporfin for cho...
OBJECTIVE: To evaluate the safety and short-term visual and fluorescein angiographic effects of a si...
Introduction Photodynamic therapy (PDT) is a method of treatment of choroidal neovascularization (CN...
BACKGROUND: Until recently, only two options were available for the treatment of choroidal neovascul...
To evaluate the safety and efficacy of verteporfin photodynamic therapy (PDT) in patients with subfo...
AIM: To evaluate the clinical efficacy and safety of photodynamic therapy(PDT)on choroidal neovascul...
PURPOSE: To describe the effects of photodynamic therapy using verteporfin for the treatment of subf...
Choroidal neovascularization in the macula is a major cause of visual disability in developed countr...
PURPOSE: To provide further information on verteporfin photodynamic therapy in occult with no classi...
BACKGROUND: Until recently, only two options were available for the treatment of choroidal neovascul...
Photodynamic therapy (PDT) using verteporfin (Visudyne®; Bausch + Lomb) is a treatment that is widel...
OBJECTIVE: To evaluate short-term safety and the effects on visual acuity and fluorescein angiograph...
OBJECTIVES: To evaluate safety and short-term visual acuity and fluorescein angiographic effects of ...
PURPOSE: To determine if photodynamic therapy with verteporfin (Visudyne; Novartis AG, Bulach, Switz...
BACKGROUND: Conventional photocoagulation of subfoveal choroidal neovascularization (CNV) is often a...
Abstract PURPOSE: To assess the effectiveness of photodynamic therapy (PDT) with verteporfin for cho...
OBJECTIVE: To evaluate the safety and short-term visual and fluorescein angiographic effects of a si...
Introduction Photodynamic therapy (PDT) is a method of treatment of choroidal neovascularization (CN...
BACKGROUND: Until recently, only two options were available for the treatment of choroidal neovascul...
To evaluate the safety and efficacy of verteporfin photodynamic therapy (PDT) in patients with subfo...
AIM: To evaluate the clinical efficacy and safety of photodynamic therapy(PDT)on choroidal neovascul...
PURPOSE: To describe the effects of photodynamic therapy using verteporfin for the treatment of subf...
Choroidal neovascularization in the macula is a major cause of visual disability in developed countr...
PURPOSE: To provide further information on verteporfin photodynamic therapy in occult with no classi...
BACKGROUND: Until recently, only two options were available for the treatment of choroidal neovascul...
Photodynamic therapy (PDT) using verteporfin (Visudyne®; Bausch + Lomb) is a treatment that is widel...
OBJECTIVE: To evaluate short-term safety and the effects on visual acuity and fluorescein angiograph...
OBJECTIVES: To evaluate safety and short-term visual acuity and fluorescein angiographic effects of ...
PURPOSE: To determine if photodynamic therapy with verteporfin (Visudyne; Novartis AG, Bulach, Switz...